arrow
J

James D. Brenton

cancer research uk cambridge institute
H指数:77
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Germline homologous recombination deficiency influences TP53-mutant clonal hematopoiesis fitness during platinum and PARP inhibitor treatment

生殖系同源重组缺陷影响铂类和PARP抑制剂治疗期间TP53突变克隆性造血的适应性

2026-09-280
OAAI
Rethinking ovarian cancer III: the past decade and future directions

重新思考卵巢癌III:过去十年及未来方向

2026-04-130
PRE
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma

BRCA缺陷性输卵管卵巢高级别浆液性癌的生存临床病理及分子预测因子

2026-04-010
OAAI
Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome

肺癌和卵巢癌对铂类化疗的治疗耐药性是由可靶向的tgf β 衰老分泌蛋白驱动的

2026-02-030
OAAI
Somatic evolution following cancer treatment in normal tissue

正常组织中癌症治疗后的体细胞进化

Nature
IF48.5
2025-12-100
OA
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

398,238名女性的全基因组关联研究揭示了七个与高级别浆液性卵巢癌相关的位点

2025-11-200
OAAI
Multi-task deep learning for automatic image segmentation and treatment response assessment in metastatic ovarian cancer

多任务深度学习在自动图像分割和转移性卵巢癌治疗反应评估中的应用

2025-09-010
OAAI
Coordinated protein modules define DNA damage responses to carboplatin at single-cell resolution in human ovarian carcinoma models

协调的蛋白质模块在人类卵巢癌模型中定义了卡铂诱导的DNA损伤反应的单细胞分辨率。

2025-08-220
OAAI
Predicting resistance to chemotherapy using chromosomal instability signatures

使用染色体不稳定性特征预测对化疗的抗性

2025-06-230
OAAI
Assessment of early response to neoadjuvant chemotherapy in multi-site high-grade serous ovarian cancer using hyperpolarized-13C MRI

多灶性高级别浆液性卵巢癌对新辅助化疗早期反应的评估:采用高极化-13C MRI技术

2025-04-170
OA
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer
2025-02-120
OAAI
Novel immunotherapeutics against LGR5 to target multiple cancer types (vol 16, pg 2233, 2024)
2024-09-251
OAAI
PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma
2024-08-260
OAAI
Novel immunotherapeutics against LGR5 to target multiple cancer types
2024-08-211
PRE
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions

整合多组学分析以确定卵巢癌风险区域的遗传和功能机制

2024-06-016
PRE